1-6 of 6
Nicholas Allen Forward
Close
Sort by
Journal Articles

Intensity of Survivin Expression Correlates with Clinical and Biological Markers of Aggressive R/R DLBCL

Sila Usta, Alexandra Misura, Kim Roos, Iran Rashedi, Irina Amitai, Yidi Jiang, Kathryn Mangoff, Gail Klein, Nicholas Allen Forward, Douglas A. Stewart, Joy Mangel, George A. Tomlinson, Hubert Tsui, Neil Berinstein
Journal: Blood
Blood (2023) 142 (Supplement 1): 6124.
https://doi.org/10.1182/blood-2023-189200
Published: 2023
Journal Articles

Next Generation BTK Inhibitor Acalabrutinib with Bendamustine-Rituximab in First Line Waldenstrom's Macroglobulinemia: The Brawm Study

Neil L Berinstein, Gail Klein, Katerina Welsh, Rebecca McClure, Nicholas Allen Forward, Mona Shafey, Anna Nikonova, David MacDonald, Diego Villa, Irwindeep Sandhu, Mohammed A Aljama, Jean-François Larouche
Journal: Blood
Blood (2022) 140 (Supplement 1): 9383–9384.
https://doi.org/10.1182/blood-2022-169245
Published: 2022
Journal Articles

Outcomes of High Grade B- Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements: An Atlantic Canadian Centre Perspective

Erica Kelly, Nicholas Allen Forward, Mary-Margaret Keating
Journal: Blood
Blood (2021) 138 (Supplement 1): 4579.
https://doi.org/10.1182/blood-2021-153585
Published: 2021
Journal Articles

Clinical Effectiveness of Combination Immunotherapy DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

Neil L Berinstein, MD, Isabelle Bence-Bruckler, MD, Nicholas Allen Forward, MDMSc,FRCPC, Pierre Laneuville, MD FRCPC, Joy Mangel, MD FRCPC, Douglas A. Stewart, MD FRCPC, Irina Amitai, MD, Gail Klein, MSc, Nancy Pennell, BSc, Iran Rashedi, MD MSc, Kim Roos, BA, BSc, Yogesh Bramhecha, Rebekah Conlon, RN
Journal: Blood
Blood (2020) 136 (Supplement 1): 16.
https://doi.org/10.1182/blood-2020-136751
Published: 2020
Journal Articles

Targeted Deep Sequencing As a Clinically Effective Approach to Profile the Mutational Landscape in Multiple Myeloma

Samuel Cutler, MSc, Dan Gaston, PhD, Philipp Knopf, Andrea Thoni, MD, Nicholas Allen Forward, MDMSc,FRCPC, Darrell J White, MD, Julie Wagner, PhD, Marissa Goudie, Manal Elnenaei, MBChB, PhD FRCPath
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137754
Published: 2020
Journal Articles

Combination of DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

Neil L Berinstein, MD, Isabelle Bence-Bruckler, MD, Pierre Laneuville, MD FRCPC, Douglas A. Stewart, MD, Nicholas Allen Forward, MDMSc,FRCPC, Liam Smyth, MDFRCPath, Gail Klein, MSc, Nancy Pennell, BSc, Kim Roos, BA, BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3236.
https://doi.org/10.1182/blood-2019-125963
Published: 2019